Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imidapril hydrochloride adverse dry cough reactions in essential hypertension
ChiCTR2400089524Phase 4Recruiting
- Sponsor
- The Third Hospital of Hebei Medical University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imidapril in essential hypertension, sponsored by The Third Hospital of Hebei Medical University. Primary endpoint: Incidence and characteristics of dry cough. Started Sep 2024; status: recruiting.
02
Drugs
imidapril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2400089524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089524.